Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sabine L. Vriezinga is active.

Publication


Featured researches published by Sabine L. Vriezinga.


The New England Journal of Medicine | 2014

Randomized Feeding Intervention in Infants at High Risk for Celiac Disease

Sabine L. Vriezinga; Renata Auricchio; E. Bravi; Gemma Castillejo; Anna Chmielewska; P. Crespo Escobar; Sanja Kolaček; S. Koletzko; Ilma Rita Korponay-Szabó; E. Mummert; Isabel Polanco; Hein Putter; Carmen Ribes-Koninckx; Raanan Shamir; H. Szajewska; Katharina J. Werkstetter; Luigi Greco; Judit Gyimesi; Corina Hartman; C. Hogen Esch; E.G.D. Hopman; Anneli Ivarsson; T. Koltai; Frits Koning; Eva Martínez-Ojinaga; C. te Marvelde; A. Mocic Pavic; Jihane Romanos; E. Stoopman; Vincenzo Villanacci

BACKGROUND A window of opportunity has been suggested for reducing the risk of celiac disease by introducing gluten to infants at 4 to 6 months of age. METHODS We performed a multicenter, randomized, double-blind, placebo-controlled dietary-intervention study involving 944 children who were positive for HLA-DQ2 or HLA-DQ8 and had at least one first-degree relative with celiac disease. From 16 to 24 weeks of age, 475 participants received 100 mg of immunologically active gluten daily, and 469 received placebo. Anti-transglutaminase type 2 and antigliadin antibodies were periodically measured. The primary outcome was the frequency of biopsy-confirmed celiac disease at 3 years of age. RESULTS Celiac disease was confirmed by means of biopsies in 77 children. To avoid underestimation of the frequency of celiac disease, 3 additional children who received a diagnosis of celiac disease according to the 2012 European Society for Pediatric Gastroenterology, Hepatology, and Nutrition diagnostic criteria (without having undergone biopsies) were included in the analyses (80 children; median age, 2.8 years; 59% were girls). The cumulative incidence of celiac disease among patients 3 years of age was 5.2% (95% confidence interval [CI], 3.6 to 6.8), with similar rates in the gluten group and the placebo group (5.9% [95% CI, 3.7 to 8.1] and 4.5% [95% CI, 2.5 to 6.5], respectively; hazard ratio in the gluten group, 1.23; 95% CI, 0.79 to 1.91). Rates of elevated levels of anti-transglutaminase type 2 and antigliadin antibodies were also similar in the two study groups (7.0% [95% CI, 4.7 to 9.4] in the gluten group and 5.7% [95% CI, 3.5 to 7.9] in the placebo group; hazard ratio, 1.14; 95% CI, 0.76 to 1.73). Breast-feeding, regardless of whether it was exclusive or whether it was ongoing during gluten introduction, did not significantly influence the development of celiac disease or the effect of the intervention. CONCLUSIONS As compared with placebo, the introduction of small quantities of gluten at 16 to 24 weeks of age did not reduce the risk of celiac disease by 3 years of age in this group of high-risk children. (Funded by the European Commission and others; PreventCD Current Controlled Trials number, ISRCTN74582487.).


Nature Reviews Gastroenterology & Hepatology | 2015

Coeliac disease and gluten-related disorders in childhood

Sabine L. Vriezinga; Joachim J. Schweizer; Frits Koning; M. Luisa Mearin

Gluten-related disorders such as coeliac disease, wheat allergy and noncoeliac gluten sensitivity are increasingly being diagnosed in children. Coeliac disease occurs frequently, affecting 1–3% of the Western population. The condition manifests at a very young age, more so in girls, and is related to the HLA genotype. Coeliac disease might be considered a public health problem and, as primary prevention is not possible, the debate on mass screening should be reopened. Wheat proteins, including gluten, are responsible for one of the most common food allergies in children: wheat allergy. Unlike coeliac disease and wheat allergy, noncoeliac gluten sensitivity is an unclear and controversial entity. These three gluten-related disorders are treated with a gluten-free diet. In coeliac disease, the diet should be strictly followed, whereas wheat allergy only requires wheat elimination and in noncoeliac gluten sensitivity occasional trials of gluten reintroduction can be done. A good diagnostic work-up is important for gluten-related disorders in childhood to avoid unnecessary restrictive diets in children. In this Review, we provide an overview of the pathogenesis, diagnosis and management of the most common gluten-related disorders in children.


The Journal of Pediatrics | 2016

Complementary Serologic Investigations in Children with Celiac Disease Is Unnecessary during Follow-Up

Margaretha Maria Susanna Wessels; Iris I. van Veen; Sabine L. Vriezinga; Hein Putter; Edmond Henri Herman Maria Rings; Maria Luisa Mearin

OBJECTIVES To determine the frequency of nutritional deficiencies and thyroid dysfunction in children with celiac disease (CD) and during follow-up after initiation of a gluten-free diet. Laboratory investigations of hemoglobin, ferritin, calcium, folate, vitamin B12, vitamin D, and thyroid function are regularly ordered in children with CD despite sufficient evidence for these. STUDY DESIGN Between 2009 and 2014, test results of hemoglobin, ferritin, folate, vitamin B12, calcium, vitamin D (25[OH]D), free thyroxin, and thyroid stimulating hormone of children with CD regularly seen at the Leiden University Medical Center were investigated. Laboratory reference ranges were used to define abnormal results. Pearson χ(2) test for trend, unpaired t test, and 1-way ANOVA were used for statistical analysis. RESULTS Of the 182 children evaluated, 119 were newly diagnosed. On average, 17% of results per year were missing because of incomplete blood investigations. Iron deficiency (28%) and iron deficiency anemia (9%) were found at the time of diagnosis of CD. Folate (14%), vitamin B12 (1%), and vitamin D deficiencies (27%) were also seen. No hypocalcemia or thyroid dysfunction was found. At follow-up, iron deficiency, iron deficiency anemia, and folate and vitamin D deficiency were observed in 8%, 2%, 3%, and 25% of patients, respectively. Vitamin B12 deficiency, hypocalcemia, and thyroid disease were not found. CONCLUSIONS Complementary blood investigations are relevant at the time of diagnosis of CD but have little diagnostic yield during follow-up visits once the patient is placed on a gluten-free diet. Thus, we recommend that these variables only be assessed on indication, such as fatigue or abnormal growth.


European Journal of Human Genetics | 2015

Impact on parents of HLA-DQ2/DQ8 genotyping in healthy children from coeliac families.

Margreet Wessels; Sabine L. Vriezinga; S. Koletzko; Katharina J. Werkstetter; Gemma Castillejo-De Villasante; Raanan Shamir; Corina Hartman; Hein Putter; Sylvia van der Pal; Cisca Wijmenga; Enzo Bravi; M. Luisa Mearin

Due to the association of coeliac disease and HLA-specificities DQ2 and DQ8, HLA-typing can be used for risk determination of the disease. This study was designed to evaluate the knowledge of parents from coeliac families regarding HLA-typing and the impact of HLA-typing on the perception of the health of their children. A structured questionnaire was sent to the Dutch, Spanish and German parents participating with their child in the European PreventCD study on disease prevention in high-risk families, addressing parents’ understanding of and attitude towards HLA-typing, distress related to HLA-typing and perceived health and health-related quality of life of their children. Sixty-eight percent of parents of 515 children returned the questionnaires, with 85% of children being DQ2/DQ8 positive. The majority of all parents answered the questions on knowledge correctly. Forty-eight percent of parents of DQ2/DQ8-negative children thought their child could develop coeliac disease. More distress was reported by parents of DQ2/DQ8-positive children (P<0.001). All parents showed few regrets and would repeat HLA-typing in future children. Perceived health and health-related quality of life were similar. In conclusion, we can say that misinterpretation of DQ2/DQ8-negative results by parents is frequent. DQ2/DQ8-positive results do not affect perceived health and health-related quality of life of children but may cause temporary negative feelings among parents. Parents of coeliac families seem to support HLA-typing.


The American Journal of Clinical Nutrition | 2017

The role of gluten consumption at an early age in celiac disease development: a further analysis of the prospective PreventCD cohort study

Paula Crespo-Escobar; Maria Luisa Mearin; David Hervás; Renata Auricchio; Gemma Castillejo; Judit Gyimesi; Eva Martínez-Ojinaga; Katharina J. Werkstetter; Sabine L. Vriezinga; Ilma Rita Korponay-Szabó; Isabel Polanco; Riccardo Troncone; Els Stoopman; Sanja Kolaček; Raanan Shamir; Hania Szajewska; Sibylle Koletzko; Carmen Ribes-Koninckx

Background: We previously found that the introduction of small quantities of gluten at 4-6 mo of age did not reduce the risk of celiac disease (CD) in a group of high-risk children. However, the consumption of high amounts of gluten early in life has been suggested to increase CD risk.Objective: The aim of this study was to evaluate this hypothesis by using data from the previous study of the PreventCD trial (www.preventcd.com).Design: Gluten intake was prospectively quantified by using specific food records between 11 and 36 mo of age in 715 children positive for the human leukocyte antigen (HLA)-DQ2 and/or HLA-DQ8 from 5 European countries. According to the PreventCD protocol, infants received 100 mg immunologically active gluten/d or placebo from 4 to 6 mo of age, with a stepwise and fixed gluten increase until age 10 mo and unrestricted intake thereafter. The primary outcome of the present study was the impact of the amount of gluten consumed from age 10 mo onward on CD development.Results: Mean daily gluten intakes from 10 mo onward were significantly different between countries for children at all ages (P < 0.001) but not between children who developed CD and those who did not within the same country (P > 0.05). The variables country, sex, intervention group, and gluten consumption pattern did not show significant associations with CD development risk (HRs not significant). In addition, the interaction between HLA risk group and gluten consumption pattern showed no significant risk on CD development, except for the DQ2.2/DQ7 haplotype (HR: 5.81; 95% CI: 1.18, 28.74; P = 0.031).Conclusions: Gluten consumption patterns as well as the amount of gluten consumed at 11-36 mo of age do not influence CD development for most related HLA genotypes in children with a genetic risk. This study reports the gluten consumption pattern in children at risk of CD from different European countries. This trial was registered at www.controlled-trials.com as ISRCTN74582487.


The Journal of Pediatrics | 2017

E-Healthcare for Celiac Disease-A Multicenter Randomized Controlled Trial

Sabine L. Vriezinga; Annelise Borghorst; Elske van den Akker-van Marle; Marc A. Benninga; Elvira K. George; Daniëlle Hendriks; Erica Hopman; Tim de Meij; Andrea E. van der Meulen-de Jong; Hein Putter; Edmond Rings; Maaike Schaart; Joachim Schweizer; Margot Smit; Merit M. Tabbers; Michel E. Weijerman; Margreet Wessels; M. Luisa Mearin

Objective To evaluate the (cost‐)effectiveness of online consultations in follow‐up of patients with celiac disease (CD). Study design Multicenter randomized, controlled trial involving 304 patients aged ≤25 years with CD for ≥1 year, randomized to an online (n = 156) or outpatient consultation (n = 148). An online consultation included questionnaires for symptom and growth measurement. Antitransglutaminase‐type‐2 antibodies were determined using a point‐of‐care (POC) test. Controls had a traditional consultation with antitransglutaminase‐type‐2 antibodies testing in laboratories. Both groups completed questionnaires concerning CD‐specific health‐related quality of life (HRQOL), gluten‐free diet adherence, and patient satisfaction. Six months later, participants repeated HRQOL and patient satisfaction questionnaires and the POC test. The primary outcome was anti‐transglutaminase‐type‐2 antibodies after 6 months, and the secondary outcomes were health problems, dietary adherence, HRQOL, patient satisfaction, and costs. Results The performance of the POC test was inferior to laboratory testing (2/156 positive POC tests vs 13/148 positive laboratory tests; P = .003). Health problems were detected significantly more frequently using online consultation. The detection of growth problems and dietary transgressions was similar. HRQOL (from 1 [good] to 5 [poor]) improved after online consultation (from 3.25 to 3.16 [P = .013] vs controls from 3.10 to 3.23; P = .810). Patient satisfaction (from 1 [low] to 10 [high]) was 7.6 (online) vs 8.0 (controls; P = .001); 58% wished to continue online consultations. Mean costs per participant during the studied period were &U20AC;202 less for the online group (P < .001). Conclusions The primary outcome could not be tested because the POC test was unreliable. Nevertheless, our results indicate that online consultations for children and young adults with CD are cost saving, increase CD‐specific HRQOL, and are satisfactory for the majority. Trial Registration Trialregister.nl: NTR3688.


PLOS ONE | 2018

The impact of human breast milk components on the infant metabolism

Christian Hellmuth; Olaf Uhl; Hans Demmelmair; Maria Grünewald; Renata Auricchio; Gemma Castillejo; Ilma Rita Korponay-Szabó; Isabel Polanco; María Roca; Sabine L. Vriezinga; Katharina J. Werkstetter; Berthold Koletzko; M. Luisa Mearin; Franca F. Kirchberg

Background & aims Breastfeeding is beneficial for mothers and infants. Underlying mechanisms and biochemical mediators thus need to be investigated to develop and support improved infant nutrition practices promoting the child health. We analysed the relation between maternal breast milk composition and infant metabolism. Methods 196 pairs of mothers and infants from a European research project (PreventCD) were studied. Maternal milk samples collected at month 1 and month 4 after birth were analysed for macronutrient classes, hormone, and fatty acid (FA) content. Phospholipids, acylcarnitines, and amino acids were measured in serum samples of 4-month old infants. Associations between milk components and infant metabolites were analysed with spearman correlation and linear mixed effect models (LME). P-values were corrected for multiple testing (PLME). Results Month 1 milk protein content was strongly associated with infant serum lyso-phosphatidylcholine (LPC) 14:0 (PLME = 0.009). Month 1 milk insulin was associated to infant acetylcarnitine (PLME = 0.01). There were no associations between milk protein content and serum amino acids and milk total fat content and serum polar lipids. Middle- and odd-chain FA% in breast milk at both ages were significantly related to serum LPC and sphingomyelins (SM) species in infant serum (all PLME<0.05), while FA% 20:5n-3 and 22:6n-3 percentages were significantly associated to serum LPC 22:6 (PLME = 1.91×10−4/7.93×10−5) in milk only at month 4. Other polyunsaturated fatty acids and hormones in milk showed only weak associations with infant serum metabolites. Conclusions Infant serum LPC are influenced by breast milk FA composition and, intriguingly, milk protein content in early but not late lactation. LPC 14:0, previously found positively associated with obesity risk, was the serum metabolite which was the most strongly associated to milk protein content. Thus, LPC 14:0 might be a key metabolite not only reflecting milk protein intake in infants, but also relating high protein content in milk or infant formula to childhood obesity risk.


Apmis | 2018

Histopathological evaluation of duodenal biopsy in the PreventCD project. An observational interobserver agreement study

Vincenzo Villanacci; Luisa Lorenzi; Francesco Donato; Renata Auricchio; Piotr Dziechciarz; Judit Gyimesi; Sibylle Koletzko; Zrinjka Mišak; Vanesa Morente Laguna; Isabel Polanco; David Ramos; Raanan Shamir; Riccardo Troncone; Sabine L. Vriezinga; M. Luisa Mearin

Aim of the current study was to evaluate the inter‐observer agreement between pathologists in the diagnosis of celiac disease (CD), in the qualified context of a multicenter study. Biopsies from the “PreventCD” study, a multinational‐ prospective‐ randomized study in children with at least one‐first‐degree relative with CD and positive for HLA‐DQ2/HLA‐DQ8. Ninety‐eight biopsies were evaluated. Considering diagnostic samples with villous atrophy (VA), the agreement was satisfactory (κ = 0.84), but much less when assessing the severity of these lesions. The use of the recently proposed Corazza‐Villanacci classification showed a moderately higher level of agreement (κ = 0.39) than using the Marsh‐Oberhuber system (κ = 0.31). 57.1% of cases were considered correctly oriented. A number of >4 samples per patient was statistically associated to a better agreement; orientation did not impact on κ values. Agreement results in this study appear more satisfactory than in previous papers and this is justified by the involvement of centers with experience in CD diagnosis and by the well‐controlled setting. Despite this, the reproducibility was far from optimal with a poor agreement in grading the severity of VA. Our results stress the need of a minimum of four samples to be assessed by the pathologist.


Clinical Nutrition | 2017

Assessment of dietary compliance in celiac children using a standardized dietary interview

Margaretha Maria Susanna Wessels; Marije te Lintelo; Sabine L. Vriezinga; Hein Putter; Erica Hopman; M. Luisa Mearin


Journal of Autoimmunity | 2016

Investigating the early metabolic fingerprint of celiac disease - a prospective approach

Franca F. Kirchberg; Katharina J. Werkstetter; Olaf Uhl; Renata Auricchio; Gemma Castillejo; Ilma Rita Korponay-Szabó; Isabel Polanco; Carmen Ribes-Koninckx; Sabine L. Vriezinga; Berthold Koletzko; M. Luisa Mearin; Christian Hellmuth

Collaboration


Dive into the Sabine L. Vriezinga's collaboration.

Top Co-Authors

Avatar

M. Luisa Mearin

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Renata Auricchio

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Isabel Polanco

Autonomous University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Hein Putter

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maria Luisa Mearin

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Judit Gyimesi

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Riccardo Troncone

University of Naples Federico II

View shared research outputs
Researchain Logo
Decentralizing Knowledge